This inventor holds 1 USPTO granted patent. Top assignee: Esteve Pharmaceuticals, S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Maria Garrido-Martinez: Innovator in Pain Management
Introduction
Maria Garrido-Martinez is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at alleviating pain. Her innovative work has led to the creation of a patented drug that showcases her expertise and dedication to improving therapeutic options.
Latest Patents
Maria Garrido-Martinez holds a patent for "Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain." This invention relates to pyrazolopyrimidine derivatives that exhibit dual pharmacological activity towards both the αδ subunit of the voltage-gated calcium channel and the sigma-1 (σ1) receptor. The patent outlines processes for preparing these compounds, pharmaceutical compositions that include them, and their therapeutic applications, particularly for pain management.
Career Highlights
Throughout her career, Maria has demonstrated a strong commitment to research and development in the pharmaceutical industry. Her work at Esteve Pharmaceuticals has positioned her as a key player in the quest for effective pain relief solutions. With her innovative approach, she has contributed to advancing the understanding of pain mechanisms and potential treatments.
Collaborations
Maria collaborates with talented professionals in her field, including Ariadna Fernandez-Donis and José-Luís Díaz-Fernández. These partnerships enhance her research efforts and contribute to the successful development of new therapeutic options.
Conclusion
Maria Garrido-Martinez is a trailblazer in the field of pain management, with her patented innovations paving the way for future advancements in pharmacology. Her dedication to improving patient outcomes through innovative research is commendable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
